These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 17222546

  • 21. Tumour length of the largest focus predicts prostate-specific antigen-based recurrence after radical prostatectomy in clinically localized prostate cancer.
    Mizuno R, Nakashima J, Mukai M, Okita H, Kosugi M, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Oya M.
    BJU Int; 2009 Nov; 104(9):1215-8. PubMed ID: 19389009
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms.
    Shariat SF, Park S, Trinh QD, Roehrborn CG, Slawin KM, Karakiewicz PI.
    J Urol; 2007 Oct; 178(4 Pt 1):1229-36; discussion 1236-7. PubMed ID: 17698116
    [Abstract] [Full Text] [Related]

  • 26. Natural history of persistently elevated prostate specific antigen after radical prostatectomy: results from the SEARCH database.
    Moreira DM, Presti JC, Aronson WJ, Terris MK, Kane CJ, Amling CL, Freedland SJ.
    J Urol; 2009 Nov; 182(5):2250-5. PubMed ID: 19758614
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The surgical learning curve for prostate cancer control after radical prostatectomy.
    Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, Reuther AM, Kattan MW, Pontes JE, Scardino PT.
    J Natl Cancer Inst; 2007 Aug 01; 99(15):1171-7. PubMed ID: 17652279
    [Abstract] [Full Text] [Related]

  • 30. Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer.
    Moussa AS, Li J, Soriano M, Klein EA, Dong F, Jones JS.
    BJU Int; 2009 Jan 01; 103(1):43-8. PubMed ID: 18782303
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy.
    Pierorazio PM, Lambert SM, Matsukhani M, Sprenkle PC, McCann TR, Katz AE, Olsson CA, Benson MC, McKiernan JM.
    BJU Int; 2007 Nov 01; 100(5):1066-70. PubMed ID: 17784880
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy.
    Chun FK, Briganti A, Lebeau T, Fradet V, Steuber T, Walz J, Schlomm T, Eichelberg C, Haese A, Erbersdobler A, McCormack M, Perrotte P, Graefen M, Huland H, Karakiewicz PI.
    Eur Urol; 2006 Feb 01; 49(2):273-8; discussion 278-9. PubMed ID: 16413103
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.
    Freedland SJ, Hotaling JM, Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL.
    Eur Urol; 2008 Apr 01; 53(4):758-64; discussion 765-6. PubMed ID: 17868976
    [Abstract] [Full Text] [Related]

  • 38. Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer.
    Fradet V, Lessard L, Bégin LR, Karakiewicz P, Masson AM, Saad F.
    Clin Cancer Res; 2004 Dec 15; 10(24):8460-4. PubMed ID: 15623625
    [Abstract] [Full Text] [Related]

  • 39. Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy.
    Guzzo TJ, Vira MA, Neway W, Hwang WT, Tomaszewski J, VanArsdalen K, Wein AJ, Malkowicz SB.
    Urology; 2007 Jun 15; 69(6):1147-51. PubMed ID: 17572204
    [Abstract] [Full Text] [Related]

  • 40. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
    Villamón-Fort R, Martínez-Jabaloyas JM, Soriano-Sarriá P, Ramos-Soler D, Pastor-Hernández F, Gil-Salom M.
    Urol Int; 2007 Jun 15; 78(4):328-33. PubMed ID: 17495491
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.